durvalumab,Oleclumab
Astrazeneca
['synergy', 'bcsm', 'durva', 'oleclumab', 'breast', 'rs onco']
#esmo22 news: synergy trial shows no clinical benefit of adding oleclumab to durvalumab plus chemo in untreated patients with advanced triple-negative breast cancer. presented by of #bcsm 
Medicine Matters #oncology publishes the latest news, commentary, research, and educational resources in a range of topics across oncology.